MX2007012703A - Compuestos de piperazina o diaza-ciclicos sustituidos por 2-amino-carbonilo como moduladores del inhibidor de la proteina de apoptosis (iap). - Google Patents
Compuestos de piperazina o diaza-ciclicos sustituidos por 2-amino-carbonilo como moduladores del inhibidor de la proteina de apoptosis (iap).Info
- Publication number
- MX2007012703A MX2007012703A MX2007012703A MX2007012703A MX2007012703A MX 2007012703 A MX2007012703 A MX 2007012703A MX 2007012703 A MX2007012703 A MX 2007012703A MX 2007012703 A MX2007012703 A MX 2007012703A MX 2007012703 A MX2007012703 A MX 2007012703A
- Authority
- MX
- Mexico
- Prior art keywords
- iap
- diaza
- modulators
- cyclic compounds
- protein inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invencion se refiere a compuestos de la Formula (I): (ver formula (I)) o a sales farmaceuticamente aceptables, solvatos, hidratos, o formulaciones farmaceuticamente aceptables de los mismos. Estos compuestos se pueden utilizar para modular la proliferacion celular, y para prevenir y/o tratar enfermedades proliferativas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005017116A DE102005017116A1 (de) | 2005-04-13 | 2005-04-13 | Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) |
PCT/US2006/013943 WO2006113376A1 (en) | 2005-04-13 | 2006-04-13 | 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007012703A true MX2007012703A (es) | 2008-01-14 |
Family
ID=36829712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007012703A MX2007012703A (es) | 2005-04-13 | 2006-04-13 | Compuestos de piperazina o diaza-ciclicos sustituidos por 2-amino-carbonilo como moduladores del inhibidor de la proteina de apoptosis (iap). |
Country Status (16)
Country | Link |
---|---|
US (2) | US7932255B2 (es) |
EP (1) | EP1874748B1 (es) |
JP (1) | JP2008536861A (es) |
KR (1) | KR20070119088A (es) |
CN (1) | CN101160297B (es) |
AT (1) | ATE439355T1 (es) |
AU (1) | AU2006236714A1 (es) |
BR (1) | BRPI0608783A2 (es) |
CA (1) | CA2604821A1 (es) |
DE (2) | DE102005017116A1 (es) |
ES (1) | ES2328405T3 (es) |
MX (1) | MX2007012703A (es) |
PL (1) | PL1874748T3 (es) |
PT (1) | PT1874748E (es) |
RU (1) | RU2007141578A (es) |
WO (1) | WO2006113376A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4954983B2 (ja) | 2005-05-18 | 2012-06-20 | ファーマサイエンス・インコーポレイテッド | Birドメイン結合化合物 |
BRPI0617751A2 (pt) | 2005-10-25 | 2011-08-02 | Aegera Therapeutics Inc | compostos de ligação do domìnio iap bir |
TWI543988B (zh) | 2006-03-16 | 2016-08-01 | 科學製藥股份有限公司 | 結合於細胞凋亡抑制蛋白(iap)之桿狀病毒iap重複序列(bir)區域之化合物 |
CN101535300B (zh) | 2006-05-16 | 2014-05-28 | 埃格拉医疗公司 | Iap bir域结合化合物 |
US20100317593A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | 2,3-dihydro-1h-indene compounds |
UY32826A (es) | 2009-08-04 | 2011-02-28 | Takeda Pharmaceutical | Compuestos heterocíclicos |
EP2534170B1 (en) | 2010-02-12 | 2017-04-19 | Pharmascience Inc. | Iap bir domain binding compounds |
JP5760078B2 (ja) | 2011-03-16 | 2015-08-05 | 田辺三菱製薬株式会社 | 含窒素飽和複素環化合物 |
WO2018093695A1 (en) * | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
CN107879997B (zh) * | 2017-12-25 | 2021-01-26 | 三峡大学 | 一种小分子抑制剂sld1338及其在制药中的应用 |
JP7515175B2 (ja) * | 2018-07-31 | 2024-07-12 | ファイメクス株式会社 | 複素環化合物 |
WO2021020585A1 (ja) | 2019-07-31 | 2021-02-04 | ファイメクス株式会社 | 複素環化合物 |
WO2023215205A1 (en) * | 2022-05-06 | 2023-11-09 | Merck Sharp & Dohme Llc | Orexin receptor agonists |
WO2024107615A1 (en) * | 2022-11-17 | 2024-05-23 | Merck Sharp & Dohme Llc | Orexin receptor agonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
ATE410439T1 (de) * | 1998-03-19 | 2008-10-15 | Vertex Pharma | Caspase inhibitoren |
JP2002533455A (ja) * | 1998-12-23 | 2002-10-08 | シェーリング コーポレイション | ファルネシルタンパク質トランスフェラーゼの新規なインヒビター |
AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
US7030141B2 (en) * | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
CA2491041A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
-
2005
- 2005-04-13 DE DE102005017116A patent/DE102005017116A1/de not_active Withdrawn
-
2006
- 2006-04-13 EP EP06769822A patent/EP1874748B1/en not_active Not-in-force
- 2006-04-13 CA CA002604821A patent/CA2604821A1/en not_active Abandoned
- 2006-04-13 RU RU2007141578/04A patent/RU2007141578A/ru not_active Application Discontinuation
- 2006-04-13 KR KR1020077026234A patent/KR20070119088A/ko not_active Application Discontinuation
- 2006-04-13 AT AT06769822T patent/ATE439355T1/de active
- 2006-04-13 US US11/911,418 patent/US7932255B2/en not_active Expired - Fee Related
- 2006-04-13 JP JP2008506709A patent/JP2008536861A/ja active Pending
- 2006-04-13 MX MX2007012703A patent/MX2007012703A/es not_active Application Discontinuation
- 2006-04-13 BR BRPI0608783-3A patent/BRPI0608783A2/pt not_active IP Right Cessation
- 2006-04-13 AU AU2006236714A patent/AU2006236714A1/en not_active Abandoned
- 2006-04-13 PL PL06769822T patent/PL1874748T3/pl unknown
- 2006-04-13 DE DE602006008447T patent/DE602006008447D1/de active Active
- 2006-04-13 ES ES06769822T patent/ES2328405T3/es active Active
- 2006-04-13 PT PT06769822T patent/PT1874748E/pt unknown
- 2006-04-13 WO PCT/US2006/013943 patent/WO2006113376A1/en active Application Filing
- 2006-04-13 CN CN2006800125373A patent/CN101160297B/zh not_active Expired - Fee Related
-
2011
- 2011-03-21 US US13/053,046 patent/US20110183955A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7932255B2 (en) | 2011-04-26 |
DE602006008447D1 (de) | 2009-09-24 |
RU2007141578A (ru) | 2009-05-20 |
WO2006113376A1 (en) | 2006-10-26 |
CN101160297A (zh) | 2008-04-09 |
US20110183955A1 (en) | 2011-07-28 |
EP1874748A1 (en) | 2008-01-09 |
JP2008536861A (ja) | 2008-09-11 |
CN101160297B (zh) | 2011-07-27 |
PT1874748E (pt) | 2009-10-28 |
US20080207630A1 (en) | 2008-08-28 |
KR20070119088A (ko) | 2007-12-18 |
ATE439355T1 (de) | 2009-08-15 |
CA2604821A1 (en) | 2006-10-26 |
ES2328405T3 (es) | 2009-11-12 |
AU2006236714A1 (en) | 2006-10-26 |
EP1874748B1 (en) | 2009-08-12 |
BRPI0608783A2 (pt) | 2010-01-26 |
DE102005017116A1 (de) | 2006-10-26 |
PL1874748T3 (pl) | 2010-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1874748E (pt) | Compostos piperazina ou diaza-cíclicos substituídos com 2-aminocarbonilo moduladores do inibidor da proteína da apoptose (iap) | |
IL260127B (en) | mek inhibitors and methods of using them | |
EA200900819A1 (ru) | Хиназолины для ингибирования pdk1 | |
PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
MX2009011211A (es) | Indoles sustituidos en la posicion 7 inhibidores de mci-1. | |
UA98297C2 (en) | Triazolopyridazines as tyrosine kinase modulators | |
MX2009006535A (es) | Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina. | |
CR7056A (es) | Derivados de 3-(4-amidopirrol-2-ilmetilden)-2-indolinona como inhibidores de la protein quinasa | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
MY146548A (en) | Certain chemicals entities, compositions, and methods | |
MX2012002542A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
MX2009004714A (es) | Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa. | |
MY153766A (en) | Derivatised proline containing peptide organic compounds as protease inhibitors | |
EA200801011A1 (ru) | Производные пиразина как модуляторы натриевых каналов для лечения боли | |
MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. | |
WO2008014229A3 (en) | Dimeric iap inhibitors | |
WO2006034391A3 (en) | Indole inhibitors of 15-lipoxygenase | |
MX2010003563A (es) | Inhibidores de proteina cinasa de c-met. | |
TW200738244A (en) | 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof | |
MX2009012079A (es) | Compuestos heterociclicos condensados como inhibidores de proteina cinasas. | |
UA96742C2 (en) | Mek inhibitors and use thereof | |
EA201990219A3 (ru) | Ингибиторы mek и способы их применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |